The current news hype about Ocrevus is simply marketing BS. Here's the new paper in NEJM, with lackluster results: http://www.nejm.org/doi/full/10.1056/NEJMoa1606468#t=article
and here's some background on the deaths, side effects and history of this drug.

While Dr. Stephen Hauser is proclaiming the "spectacular" results of the latest immune cell suppressing therapy, ocrelizumab, other MS resea...